Additional information
Off white Powder
1391052-00-8
ACI-011235
NA
C66H64F2N4O10.Ca2+
1151.31
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
2-(4-Fluorophenyl)-?-hydroxy-5-(1-methylethyl)-?-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calciumsalt (rac-3-Oxo-Atorvastatin Calcium salt)
2-(4-Fluorophenyl)-d-hydroxy-5-(1-methylethyl)-ß-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium Salt
rac-3-Oxo-Atorvastatin Calcium salt





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)